Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-20-213033
Filing Date
2020-08-07
Accepted
2020-08-07 16:10:28
Documents
3
Effectiveness Date
2020-08-07

Document Format Files

Seq Description Document Type Size
1 S-8 d17716ds8.htm S-8 47996
2 EX-5.1 d17716dex51.htm EX-5.1 4774
3 EX-23.1 d17716dex231.htm EX-23.1 1693
  Complete submission text file 0001193125-20-213033.txt   55666
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-242327 | Film No.: 201085297
SIC: 2834 Pharmaceutical Preparations